NCT07248371 Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases
| NCT ID | NCT07248371 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chang Gung Memorial Hospital |
| Condition | Metabolic Syndrome (MetS) |
| Study Type | OBSERVATIONAL |
| Enrollment | 6,266 participants |
| Start Date | 2025-06-09 |
| Primary Completion | 2028-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 6,266 participants in total. It began in 2025-06-09 with a primary completion date of 2028-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to validate integrative multi-omics approaches for understanding complications related to metabolic syndrome. By combining genetic, transcriptomic, metabolomic, and microbiome data from participants with and without metabolic syndrome, the research seeks to determine which biological factors predict disease progression and how these insights can inform precision prevention and treatment strategies for metabolic disorders.
Eligibility Criteria
Inclusion Criteria: * Individuals (male or female) aged 20 years or older * Willing and able to provide written informed consent to participate in the study Exclusion Criteria: * Pregnant or breastfeeding women * Patients with end-stage renal disease receiving hemodialysis or peritoneal dialysis * Individuals currently undergoing active cancer treatment * Recipients of any organ transplantation * Patients diagnosed with dementia
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07248371 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Metabolic Syndrome (MetS). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07248371 currently recruiting?
Yes, NCT07248371 is actively recruiting participants. Contact the research team at yehccl@cgmh.org.tw for enrollment information.
Where is the NCT07248371 trial being conducted?
This trial is being conducted at Taoyuan, Taiwan.
Who is sponsoring the NCT07248371 clinical trial?
NCT07248371 is sponsored by Chang Gung Memorial Hospital. The trial plans to enroll 6,266 participants.